. Region 3, the C-terminal half (AAs 41 to 98), contains a possible zinc finger structure (1, 8) . Two metal-binding motifs, Cys-X-X-Cys, are separated by a stretch of 29 AAs (Fig. 1) . Like HPV 16, HPV 18 (3, 4) and HPV 6 (34) show similar E7 structural features (Fig. 1) .
Human papillomavirus type 16 (HPV 16) (5) is believed to cause cervical cancers (for review, see reference 47) , and its open reading frame, E7, encodes a small nuclear (33) oncoprotein composed of 98 amino acid (AA) residues (35) . Expression of the E7 gene can induce cell DNA synthesis in serum-starved, contact-inhibited rat 3Y1 cells (32) . The E7 gene is immortalizing and transforming for primary rat cells (17, 39) and established lines of mouse and rat cells (15, 28) and is capable of transforming primary human fibroblasts in cooperation with the E6 gene (42) . The E7 gene can transactivate the adenovirus E2 promoter (28) . The E7 protein is nuclear when the E7-expressing monkey COS-1 cells are examined by the immunofluorescence method (33) , although it is found in the cytoplasmic fraction upon subcellular fractionation (33, 37) . The functions and localization of E7 resemble those of adenovirus ElA and simian virus 40 (SV40) large-T, well-studied viral nuclear oncoproteins (26, 41) . It was recently reported that, like ElA and SV40 T antigens, HPV 16 E7 protein is able to bind to the retinoblastoma gene product (6) .
The nucleotide sequences of HPV DNAs enable us to deduce the AA sequences of E7 and other HPV proteins (4, 34, 35) . From the structural features, the HPV 16 E7 protein can be tentatively divided into three regions (Fig. 1 ). Region 1 (the N-terminal 20 AAs) and region 2 (AAs 21 to 40) show high homology to parts of adenovirus ElA (26, 28) . AAs 2) , respectively, of adenovirus 5 ElA, both of which constitute the essential regions for the ElA transforming function (21, 26, 27, 45) . Region 3, the C-terminal half (AAs 41 to 98), contains a possible zinc finger structure (1, 8) . Two metal-binding motifs, Cys-X-X-Cys, are separated by a stretch of 29 AAs (Fig. 1) . Like HPV 16, HPV 18 (3, 4) and HPV 6 (34) show similar E7 structural features (Fig. 1) .
In this study, we prepared various HPV 16 E7 mutants by introducing deletions into the E7 gene and by site-directed * Corresponding author. mutagenesis and examined their capabilities to exert transactivating and transforming functions. Recently, Edmond and Vousden (7) reported a point-mutational analysis of HPV 16 E7 protein.
MATERIALS AND METHODS
Plasmids. Plasmids used in this study were pSV2-E7P (15), pSV2-0 (40), pE2CAT (14) , pEJ6.6 (36), pSV2neo (38) , and pSVneo-E6 (15) . Plasmid pSV2-E7P expresses the HPV 16 E7 gene controlled by the SV40 promoter. It contains an HPV 16 DNA fragment, nucleotides (nt) 554 to 874 (spanning the entire coding region for E7), inserted at the HindIIl site into vector pSV2-0 containing SV40 transcriptional regulatory elements (promoter-enhancer, intron, and polyadenylation site). Mutants of HPV 16 E7 were constructed from pSV2-E7P. In pE2CAT, which was used as a reporter of transactivation by E7, the bacterial chloramphenicol acetyltransferase gene is placed under the control of the adenovirus 5 E2 promoter. Plasmid pEJ6.6, which was used in cotransfection for determination of the immortalizing function of E7, contains the activated ras oncogene. Plasmid pSV2neo expresses the neomycin (G418) resistance gene under the control of the SV40 promoter. For determination of the transforming function of E7 for WI38 human fibroblasts, pSVneo-E6 was used for cotransfection with mutated pSV2-E7 plasmids. Plasmid pSVneo-E6 contains an HPV 16 E6 (nt 25 to 657) transcription unit (15) inserted into pSV2neo at the BamHI site. Escherichia coli HB101 was used for propagation of all plasmids except pEJ6.6, for which E. coli DH-1 was used. Preparation and purification of plasmids were done by standard methods (22) .
Cells. Monkey COS-1 (9) and CV-1 cell lines, the rat 3Y1 cell line (18) , primary baby rat kidney (BRK) cells, and primary human fibroblasts, W138 (13) , were used in this study. The (3) and its E7 is transforming (44) . The E7 proteins are divided into three regions. Regions 1 and 2 show homology to the AA sequences in conserved domains 1 and 2, respectively, of adenovirus ElA (28) . Region 3 contains two metal-binding motifs Cys-X-X-Cys (underlined).
were used to detect production of E7 protein by immunofluorescence staining (33) and immunoprecipitation (33) . CV-1 cells, grown in Dulbecco modified Eagle medium with 10% fetal bovine serum, were used to determine the transactivating function of E7. Rat cell line 3Y1, grown in minimum essential medium with 10% fetal bovine serum, was used to measure the E7 function to induce focal transformation (16) . Primary BRK cells were prepared from 5-day-old Fischer rats. The cells were grown in Dulbecco modified Eagle medium with 10% fetal bovine serum and were used at passage 3 for determination of E7 immortalizing function (23) . WI38 primary human fibroblasts, the gift of Y. Doi (Japan Poliomyelitis Institute), were used at 25 to 30 population doublings for determination of E7 transforming function, as described previously (42) .
Antisera. Rabbit antisera raised against bacterial fusion protein HPV 16 lac-E7 were used for immunofluorescence detection (33) and immunoprecipitation (33) of E7 protein.
Preparation and characterization of HPV 16 lac-E7 protein and anti-lac-E7 sera were described previously (33 (31) around the site of intended mutation. For confirmation, the entire E7 coding region was sequenced for each selected mutant by the dideoxy method (31) . The E7 HindlIl fragments with mutations, isolated from replicative forms, were inserted into pSV2-0 vectors in a sense orientation. In mutants 7H02D and 7L13S, C at nt 565 and T at nt 599 were replaced with G and C, respectively. (2) . Samples of cytoplasmic fractions were analyzed as described previously (33) . In chase experiments, the labeled cultures were maintained for 60 min in medium without 35S-labeled AAs before subcellular fractionation.
Analysis of RNA. Total RNA extracted from the pSV2 plasmid-transfected COS-1 cultures 48 h after transfection was analyzed by the Northern (RNA) blot method (20) as described previously (42) . RNA on membrane filters was probed with HPV 16 E7 DNA fragment (nt 554 to 874) labeled with 32P by nick translation (30) .
Assay for transactivation by E7. CV-1 cells (60-mm dish) were transfected with pE2CAT (5 ,ug) and pSV2-E7P or pSV2 plasmids containing mutated E7 (5 ,ug) by the calcium coprecipitation method (11) under conditions used previously (43) . Chloramphenicol acetyltransferase activities were assayed for [14C]-chloramphenicol (Amersham International plc, Buckinghamshire, England) with the cell extracts prepared 48 h after transfection, as described by Gorman et al. (10) .
Assay for focal transformation of rat 3Y1 cells by E7. The capacity of pSV2-E7P or pSV2 plasmids with mutated E7 to induce focal transformation was examined in rat 3Y1 cells, an immortalized normal cell line, as described previously (16) . Plasmids (10 ,ug) were transfected to subconfluent rat 3Y1 cells (30-mm dish) by the calcium coprecipitation method (11) . Foci were scored 4 to 5 weeks after transfection with cultures stained with 5% Giemsa.
Assay for immortalization of primary rat cells by E7. The immortalizing function was assayed as described by Matlashewski et al. (23) . Primary BRK cells were cotransfected with pEJ6.6, pSV2 plasmids with mutated E7, and pSV2neo (5 ,ug each for a 60-mm dish culture) by the calcium coprecipitation method (11) . Some 3 to 4 weeks after transfection, the cultures (resistant to G418 [Sigma Chemical Co., St. Louis, Mo.]) were fixed with methanol and stained with 5% Giemsa. Foci of the cells characteristic of those cotransformed by E7 and activated ras were scored.
Assay for E7 transforming function for human cells. The ability of the E7 gene to transform human cells (to extend the life span) in cooperation with the E6 gene was examined in W138 primary human fibroblasts (42) . Plasmids (with or without mutation) pSV2-E7 and pSVneo-E6 (5 ,ug each) were cotransfected to W138 cells by the calcium coprecipitation method (11) . The G418-resistant cells were maintained and processed essentially as described by Pirisi et al. (29) . Cultures containing cells surviving beyond 65 population doublings were regarded as transformation positive (42 (Fig. 3A and B) , the 774 E7-positive nuclei contained condensed masses of immunofluorescence (Fig.  3C, D, Capacity to activate chloramphenicol acetyltransferase expression from the adenovirus E2 promoter was examined with pSV2 plasmids containing the mutated E7 (Fig. 2) in monkey CV-1 cells. Cell extracts prepared from cultures 48 h after transfection were measured for ability to convert chloramphenicol to acetylated forms; the relative activities (compared with backbone vector pSV2-0 and wt E7) are shown in Table 1 . The transactivating function was lowered by all mutations shown in Fig. 2 , but it was less affected by the deletion of AAs 96 to 98 at the C terminus or AAs 30 to 31 than by the other deletions.
Transforming functions of the mutated E7 genes were tested in rat 3Y1 cells, primary BRK cells, and W138 primary human fibroblasts. The E7 gene controlled by the SV40 promoter is capable by itself of focal transformation of immortalized rat 3Y1 cells (15) . pSV2 plasmids with the mutant E7 genes (Fig. 2) were transfected into 3Y1 cells, and foci of the transformed cells were scored 4 to 5 weeks later ( Some of the E7 deletion mutants (774, 54/61, and 791) and the single-AA substitution mutants shown in Fig. 4 (all mutants were placed under the control of the SV40 promoter in pSV2-0) were transfected into monkey COS-1 cells, in which production of E7 mRNA and E7 protein was examined 48 h after transfection. Total RNA from the transfected cells was electrophoresed and subjected to Northern blot analysis. E7-specific RNA of 1.4 kilobases in length was detectable in all cases (data not shown). The transfected cultures were labeled with 35S-AAs for 1 h and subjected to subcellular fractionation. Cytoplasmic fractions, in which the radiolabeled E7 protein is found almost exclusively (33, 37) , were allowed to react with anti-lac-E7, and the resulting immunocomplexes were electrophoresed in sodium dodecyl sulfate gels (Fig. 5A) . Except for 774 and 54/61, 19S E7 protein bands were detected in all cases. The level of radioactive E7 (darkening of the negatives) was significantly lower in pSV2-7C94G-transfected cells than in the other positive cases. Chase experiments (Fig. SB) revealed that the 7H02D protein was significantly more stable than wt E7. The 791 protein seemed to be slightly less stable than wt E7 protein. The low levels of 7C94G and 791 proteins probably reflect the instability of these proteins, because E7 mRNA levels were all similar to one another (data not shown). Table 2 summarizes the E7 functions of the single-AA substitution mutants shown in Fig. 4 . The steady-state nuclear E7 protein expressed in COS-1 cells and detected by immunofluorescence staining tended to be less affected in the mutations in the N-terminal (regions 1 and 2) than in the C-terminal (region 3) half. The capacity to transactivate the adenovirus E2 promoter in CV-1 cells was lowered in all of the mutants. It virtually disappeared upon changing Cys-24 to Gly, but was less affected by changes of Leu-13' and Cys-68 than by other changes. The ability to induce focal transformation of rat 3Y1 cells was eliminated by changing His-2 to Asp and Cys-24 to Gly. The transforming capacity was somewhat lowered in the mutants when Leu-13 or Cys-68 was changed to Ser or Gly, respectively. The activity was greatly lowered by the other changes (Cys-61 and Cys-94 to Gly).
Two mutants behaved differently in transformation function. The ability to transform human WI38 cells (in cooperation with E6) survived the change of His-2 to Asp, which eliminated the ability to transform rat 3Y1 cells. The transforming function for W138 cells was abolished by the change of Leu-13 to Ser, which lowered the transforming activity for rat 3Y1 cells only slightly. The change of Cys-24 to Gly, however, abolished the transforming activity for both rat and human cells. The transforming function of E7 for both rat and human cells survived the mutation at Cys-68. The transforming activities for human cells in the other mutants (Cys-61 and Cys-94) were lowered to undetectable levels. Mutant 7CC/G seemed to be weakly transforming for W138 cells. DISCUSSION The 98-AA-long HPV 16 E7 protein consists of three regions (Fig. 1) . Regions 1 and 2 show high homology to the VOL. 64, 1990 were labeled with 15S-AAs for 1 h at 48 h after transfection. Labeled cells were subjected to subcellular fractionation (2) , and the cytoplasmic fractions were mixed with anti-lac-E7 serum. Immunocomplexes were electrophoresed in a sodium dodecyl sulfate-12% polyacrylamide gel. (B) Duplicate transfected cultures were prepared: one (lanes 1, 3, 5, 7, and 9) was processed as described for panel A; the other (lanes 2, 4, 6, 8, and 10) was chased for 60 min and then processed in the same way. Cultures were transfected with pSV2-791 (lanes 1 and 2), pSV2-7H02D (lanes 3 and 4), pSV2-7C94G (lanes 5 and 6), pSV2-7CC/G (lanes 7 and 8), and pSV2-E7P (lanes 9 and 10).
AA sequences of conserved domains 1 and 2, respectively, of adenovirus ElA, both of which are essential for ElA transformation functions (21, 26, 27, 45) . Region 3 contains two metal-binding motifs, Cys-X-X-Cys. Among the three regions, the AA sequences of region 2 in HPV 16, 18, and 6 are most highly conserved (Fig. 1) . In this study, we constructed frameshift mutants, deletion mutants (Fig. 2) , and single-AA substitution mutants of HPV 16 E7 (Fig. 4) and examined their biological functions expressed under control of the SV40 promoter (Tables 1 and 2 ; Fig. 3 and 5) . Our study revealed some essential and nonessential AAs in the E7 protein for its functions. (42) .
Stability of the E7 protein expressed in monkey cells appeared to be affected by some of the mutations. Because the mRNA levels in the transfected cells were not much different among the cultures transfected with various mutants, it is likely that the mutants with lowered efficiency in inducing steady-state nuclear E7 (Tables 1 and 2 ) and a lowered level of labeled E7 protein (Fig. 5 ) produce mutant proteins that are less stable than wt E7 protein. The mutations in region 3 appeared to decrease the stability of the E7 protein more than those in regions 1 and 2 did. Clearly, the mutations affecting Cys-X-X-Cys motifs decreased the probable stability of E7 protein and its activities. It may be that the metal-binding motifs, especially that at AAs 91 to 94 of HPV 16, are important for the E7 protein to form a stable structure by binding zinc. Unlike the other mutations, the change of His-2 to Asp caused extension of the half-life of E7 protein (Fig. 5) . It is unclear at present whether or not the stability of mutant protein varies with the species from which the cells expressing E7 protein originate.
The E7 transactivating function for the adenovirus E2 promoter in monkey CV-1 cells was lowered to various degrees by the mutations examined in this study. Expression of the full activity (of wt-E7) seemed to require the entire length of E7. In region 1, the His-2 mutation markedly lowered the transactivating function, but the Leu-13 mutation did so less markedly. In region 2, the Cys-24 mutation eliminated the transactivating function, which survived (with lowered activity) the deletion of Asp-Ser-Ser (AAs 30 to 32). In region 3, the Cys-68 mutation, which is unrelated to the metal-binding motif, lowered the function less markedly than the other Cys mutations in the metal-binding motif did (in mutants 790, 791, 7C61G, and 7C94G). Thus, all regions are required for efficient transactivating function, and in region 3 the metal-binding motifs seem to be important.
The transactivating function of the mutants for the E2 promoter was also tested in rat 3Y1 cells (data not shown). The activity in 3Y1 cells was about 1/10 of that in CV-1 cells. Although the data fluctuated from experiment to experiment (especially for mutants with low activity), the activities in 3Y1 cells tended to parallel those in CV-1 cells. All three regions of E7 were found to contain AAs susceptible to the mutations that eliminate or greatly lower the capacity to transform rat 3Y1 cells (Tables 1 and 2 ). In region 1, His-2 was essential, but Leu-13 was nonessential for transformation of rat cells. In region 2, Cys-24, which was essential for E7 transactivation function, was also essential for transformation of rat cells. Asp-Ser-Ser (AAs 30 to 32) and Ser-Ser (AAs 31 to 32) were nonessential, but deletion of these amino acids (7DSS and 7SS) lowered efficiency of transformation of rat cells. In region 3, the transforming capacity seemed to be especially susceptible to destruction of metal-binding motifs. Mutations involving Cys-61 and Cys-94 (790, 791, 7C94G, 54/61, and 7C61G) drastically lowered or abolished transformation of rat cells, but the transformation function survived mutation between the two metal-binding motifs (7C68G). Thus, all three regions of E7 protein appear to be required for efficient transformation by E7.
From the AA sequence homology, regions 1 and 2 of E7 are expected to function like adenovirus ElA domains 1 and 2, respectively. Like ElA (21, 26, 27, 45) , both regions 1 and 2 of E7 seem to be required for transformation. In fact, the results obtained with the mutants in region 2 are similar to those obtained with the ElA mutants in domain 2 (45) . Cys-24 of E7 and Cys-124 of ElA are both essential for the respective transformation function. Like Ser-132 of ElA, Ser-31 and Ser-32 of E7 are nonessential but necessary for efficient transformation. Since ElA domains 1 and 2 are known to contain the binding sites for cellular target proteins, including retinoblastoma gene product (12, 46) , E7 regions 1 and 2 are expected to play similar roles (6) , which should be examined with the mutants in future studies.
Whereas the immortalizing function (transformation in conjunction with activated ras) for primary rat cells paralleled the transforming function for rat 3Y1 cells, the transformation function (in cooperation with the E6 gene) for human WI38 cells did not agree with that for rat cells in some mutants in region 1. Changing His-2 to Asp abolished the transforming function for rat cells, but not the transforming function for human cells. Changing Leu-13 to Ser, on the other hand, did not affect the transforming function for rat cells much, but eliminated the function for W138 cells. It may be that the difference in host range of these mutants results from the difference between the two species of cellular target proteins binding to region 1 (6, 12, 46 
